BBA
REGN icon

Baader Bank Aktiengesellschaft’s Regeneron Pharmaceuticals REGN Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.26M Buy
6,811
+3,958
+139% +$3.03M 0.41% 58
2025
Q4 		$2.2M Buy
2,853
+291
+11% +$198K 0.15% 108
2025
Q3 		$1.44M Sell
2,562
-11,727
-82% -$6.63M 0.09% 139
2025
Q2 		$7.5M Buy
+14,289
New +$7.98M 0.54% 48
2025
Q1 		– Sell
-866
Closed -$617K – 483
2024
Q4 		$617K Sell
866
-79
-8% -$66.3K 0.04% 206
2024
Q3 		$992K Sell
945
-22
-2% -$24.5K 0.06% 181
2024
Q2 		$1.01M Buy
967
+262
+37% +$254K 0.06% 176
2024
Q1 		$679K Sell
705
-35
-5% -$33.3K 0.05% 202
2023
Q4 		$648K Sell
740
-19
-3% -$15.6K 0.05% 181
2023
Q3 		$622K Buy
759
+29
+4% +$22.8K 0.04% 190
2023
Q2 		$525K Sell
730
-99
-12% -$76.3K 0.03% 243
2023
Q1 		$678K Buy
829
+19
+2% +$14.3K 0.03% 217
2022
Q4 		$584K Hold
810
– – 0.03% 254
2022
Q3 		$558K Sell
810
-240
-23% -$151K 0.04% 255
2022
Q2 		$621K Sell
1,050
-230
-18% -$150K 0.05% 245
2022
Q1 		$894K Hold
1,280
– – 0.07% 148
2021
Q4 		$808K Buy
+1,280
New +$787K 0.06% 186

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Baader Bank Aktiengesellschaft's REGN Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft increased its Regeneron Pharmaceuticals (REGN) stake by 139% in Q1 2026, buying an estimated $3.03M and bringing the position to 6,811 shares worth $5.26M. The position accounts for 0.41% of the portfolio, ranked #58.

Baader Bank Aktiengesellschaft first reported a position in REGN in Q4 2021 and has held it in 17 quarters since. The position peaked at $7.5M in Q2 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Baader Bank Aktiengesellschaft held 6,811 shares of Regeneron Pharmaceuticals worth $5.26M as of Q1 2026.
  • Baader Bank Aktiengesellschaft bought 3,958 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $3.03M.
  • Regeneron Pharmaceuticals made up 0.41% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #58 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 17 quarters since.
  • Baader Bank Aktiengesellschaft's Regeneron Pharmaceuticals position peaked at $7.5M in Q2 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.